Association of MGMT-535G>T polymorphism with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

被引：0
|
作者：
Chae, Y.
Kim, J.
Sohn, S.
Kang, B.
Ryoo, H.
Bae, S.
Choi, G.
Baek, J.
Kim, Y.
Cho, Y.
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Kyungpook Natl Univ Sch Med, Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Taegu, South Korea
[3] Daegu Catholic Univ Hosp, Taegu, South Korea
[4] Daegu Catholic Univ Coll Med, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea
[5] Ulsan Univ Hosp, Ulsan, South Korea
[6] Dongkuk Univ Hosp, Kyungju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14067
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer:: a real entity?
    Sebagh, M
    Plasse, M
    Lévi, F
    Adam, R
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 331 - 331
  • [22] ADDITION OF CETUXIMAB TO OXALIPLATIN-BASED CHEMOTHERAPY ON LIVER AND SPLEEN SIZE AND THROMBOCYTOPENIA IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Lee, Victor
    Fang, Weijia
    Lam, K. O.
    Choi, Cheukwai
    Ng, Sherry
    Ho, Garrett
    Cheng, Thomas
    Liu, Rico
    Leung, T. W.
    Kwong, D. L. W.
    Zheng, Shusen
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [23] Outcomes in patients (pts) with colorectal cancer (CRC) treated with oxaliplatin-based chemotherapy (OC) following prior oxaliplatin exposure
    Bhadkamkar, Nishin Anil
    Sahin, Ibrahim Halil
    Shen, Yehua
    Hassabo, Hesham Mohamed
    Kee, Bryan K.
    Hassan, Manal
    Garrett, Chris R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [24] Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Bahrami, Afsane
    Amerizadeh, Forouzan
    Hassanian, Seyed Mahdi
    ShahidSales, Soodabeh
    Khazaei, Majid
    Maftouh, Mina
    Ghayour-Mobarhan, Majid
    Ferns, Gordon A.
    Avan, Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (03) : 2193 - 2201
  • [25] Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy
    Sun, Xicai
    Yuan, Wei
    Hao, Furong
    Zhuang, Wenzhen
    MEDICAL SCIENCE MONITOR, 2017, 23 : 5389 - 5395
  • [26] Organic cation transporter 2 and tumor budding as independent prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Tatsumi, Shigenobu
    Matsuoka, Hiroshi
    Hashimoto, Yumi
    Hatta, Kohei
    Maeda, Kotaro
    Kamoshida, Shingo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (01): : 204 - 212
  • [27] Role of Calcium/Magnesium Infusion in Oxaliplatin-Based Chemotherapy for Colorectal Cancer Patients
    Kurniali, Peter C.
    Luo, Lu Guang
    Weitberg, Alan B.
    ONCOLOGY-NEW YORK, 2010, 24 (03): : 289 - 292
  • [28] Definition of oxaliplatin sensitivity in patients with advanced colorectal cancer previously treated with oxaliplatin-based therapy
    de Gramont Lesparre, A. H.
    Chibaudel, B.
    Bourges, O.
    Perez-Staub, N.
    Tournigand, C.
    Maindrault-Goebel, F.
    Andre, T.
    Larsen, A. K.
    Afchain, P.
    Louvet, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Irinotecan and mitomycin C (MMC) as salvage therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidine, irinotecan and/or oxaliplatin based chemotherapy.
    Rodriguez, I
    Viudez, A
    Salgado, E
    García-Foncillas, J
    De La Cámara, J
    Espinós, J
    Garrán, C
    Chopitea, A
    Fernández-Hidalgo, O
    Martín-Algarra, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 308S - 308S
  • [30] Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer
    Yamamoto, Seiji
    Fujii, Hironori
    Murayama, Kotaro
    Iihara, Hirotoshi
    Watanabe, Daichi
    Yamada, Yunami
    Kobayashi, Ryo
    Kiyama, Shigeru
    Makiyama, Akitaka
    Urano, Kimihiko
    Matsuhashi, Nobuhisa
    Matsuura, Katsuhiko
    Suzuki, Akio
    ANTICANCER RESEARCH, 2023, 43 (11) : 5099 - 5105
12345